טוען...
A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy vs. Recommended Two-Drug Therapy for Neisseria gonorrhoeae Infection
BACKGROUND: Novel approaches to combating drug-resistant Neisseria gonorrhoeae infections are urgently needed. Targeted therapy with ciprofloxacin has been made possible by a rapid assay for genotyping the gyrase A (gyrA) gene; a non-mutated gene reliably predicts susceptibility to ciprofloxacin. ME...
שמור ב:
| הוצא לאור ב: | Sex Transm Dis |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6879096/ https://ncbi.nlm.nih.gov/pubmed/29329176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/OLQ.0000000000000698 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|